Baylor University Medical Center Proceedings January 2014, Volume 27, Number 1 | Page 32

8.

9.
10.

11.

12.

13.

30

Isaacson P Campo E, Harris N. Large B cell lymphoma arising in HHV-8
,
associated multicentric Castleman disease. In WHO Classification: Tumours of
Haematopoietic and Lymphoid Tissues. Lyon, France: IARC Press, 2008:258–
259.
Peterson BA, Frizzera G. Multicentric Castleman’s disease. Semin Oncol
1993;20(6):636–647.
Yoshizaki K, Matsuda T, Nishimoto N, Kuritani T, Taeho L, Aozasa K,
Nakahata T, Kawai H, Tagoh H, Komori T, et al. Pathogenic significance of
interleukin-6 (IL-6/BSF-2) in Castleman’s disease. Blood 1989;74(4):1360–
1367.
Pantaleo G, Graziosi C, Demarest JF, Butini L, Montroni M, Fox CH,
Orenstein JM, Kotler DP, Fauci AS. HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease. Nature
1993;362(6418):355–358.
Oksenhendler E, Carcelain G, Aoki Y, Boulanger E, Maillard A, Clauvel
JP, Agbalika F. High levels of human herpesvirus 8 viral load, human
interleukin-6, interleukin-10, and C reactive protein correlate with
exacerbation of multicentric Castleman disease in HIV-infected patients.
Blood 2000;96(6):2069–2073.
Burger R, Neipel F, Fleckenstein B, Savino R, Ciliberto G, Kalden JR,
Gramatzki M. Human herpesvirus type 8 interleukin-6 homologue is

14.

15.

16.
17.

functionally active on human myeloma cells. Blood 1998;91(6):1858–
1863.
Oksenhendler E, Boulanger E, Galicier L, Du MQ, Dupin N,
Diss TC, Hamoudi R, Daniel MT, Agbalika F, Boshoff C, Clauvel
JP, Isaacson PG, Meignin V. High incidence of Kaposi sarcomaassociated herpesvirus-related non-Hodgkin lymphoma in patients
with HIV infection and multicentric Castleman disease. Blood
2002;99(7):2331–2336.
Aaron L, Lidove O, Yousry C, Roudiere L, Dupont B, Viard JP. Human
herpesvirus 8-positive Castleman disease in human immunodeficiency
virus-infected patients: the impact of highly active antiretroviral therapy.
Clin Infect Dis 2002;35(7):880–882.
Bower M. How I treat HIV-associated multicentric Castleman disease.
Blood 2010;116(22):4415–4421.
Sparano JA, Lee JY, Kaplan LD, Levine AM, Ramos JC, Ambinder
RF, Wachsman W, Aboulafia D, Noy A, Henry DH, Von Roenn J,
Dezube BJ, Remick SC, Shah MH, Leichman L, Ratner L, Cesarman E, Chadburn A, Mitsuyasu R; AIDS Malignancy Consortium.
Rituximab plus concurrent infusional EPOCH chemotherapy is highly
eff ective in HIV-associated B-cell non-Hodgkin lymphoma. Blood
2010;115(15):3008–3016.

Baylor University Medical Center Proceedings

Volume 27, Number 1